| Project/Area Number |
20790106
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Drug development chemistry
|
|---|
| Research Institution | Otani Womens University |
|---|
Principal Investigator |
IKEJIRI Masahiro Otani Womens University, 薬学部, 講師 (00412396)
|
|---|
| Research Collaborator |
OHSHIMA Takayuki 徳島文理大学, 香川薬学部, 准教授
MARUYAMA Tokumi 徳島文理大学, 香川薬学部, 教授
|
|---|
| Project Period (FY) |
2008 – 2010
|
| Project Status |
Completed (Fiscal Year 2010)
|
| Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2010: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2009: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2008: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
|
|---|
| Keywords | 医薬品化学 / ウイルス / 核酸 / 複素環 / 有機化学 / 合成化学 / 薬学 |
|---|
| Research Abstract |
Hepatitis C is an infectious disease affecting the liver, caused by the hepatitis C virus. In Japan, there are many patients suffering from the disease. Common medicines are effective to some extent, but not enough. Thus, I planned to study on the synthesis of novel compounds designed originally aiming to produce a new medicine. Unfortunately, the chemicals obtained were not so effective to the virus. However, interestingly, I found that they are likely to operate via a new type of mechanism that is different from that of the common antiviral drugs.
|
